Gritstone Bio

Entity > Corporation > US > New York City New York > Gritstone Bio

About Gritstone Bio

Gritstone bio is a clinical stage biotechnology company engaged in the development of immunotherapies for various cancers and infectious diseases.

Gritstone bio's Proprietary Technologies: Gritstone bio's unique approach to immunotherapy rests on two key platforms; Target Identification (Gritstone EDGE) and Antigen Delivery (Proprietary Vaccine Platform Drives Potent Immune Response)

Gritstone bio EDGE: The first platform of Gritstone bio's immunotherapy is to understand the antigens and neoantigens and in particular those that are transcribed, translated, processed and presented on the cell surface by human leukocyte antigen (HLA) molecules and thus visible to T cells. Gritstone achieves this by using Gritstone EDGE, our proprietary artificial intelligence-based platform.

Proprietary Vaccine Platform Drives Potent Immune Response: The second platform is Gritstone bio's ability to embed the immunogen into the proprietary delivery systems or vectors to promote the generation of T cells and neutralizing antibodies (nAbs) and stimulate the immune system to attack and destroy diseased cells.

Headquarters and Foundation of Gritstone Bio: The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, Calif.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Gritstone Bio

Company Attribute Value
Address StreetAddress: 5959 Horton St Ste 300, AddressLocality: Emeryville, AddressRegion: California, PostalCode: 94608, AddressCountry: United States
Founding Date 2015
Name Gritstone Bio
Number Of Employees 201
Revenue $15,712,000 USD
Ticker Symbol NASDAQ: GRTS
Url gritstonebio
Facebook facebook
Linkedin linkedin
Twitter twitter
Wikipedia wikipedia
Google google
Wikidata wikidata

Gritstone Bio


New York City, US
15 Apr 2024

New York City, US
15 Apr 2024

Gritstone Bio

Page: 1 Desktop | Laptop Devices
Gritstone bio
Gritstone's goal is to develop groundbreaking immunotherapies for cancers and infectious diseases. Our approach focuses on generating a therapeutic immune ...
Gritstone bio
Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and ... › 2024/04/02 › gritstone-bio-...
Gritstone Bio says personalized cancer vaccine falls short in ...
Apr 2, 2024 — Gritstone Bio said Monday afternoon that its personalized cancer vaccine didn't induce more responses than standard of care in a trial for ...
Gritstone bio (@gritstonebio) · X › quote › GRTS
Gritstone bio, Inc. (GRTS) Stock Price, News, Quote & History
Gritstone bio ( NASDAQ:GRTS ) Full Year 2023 Results Key Financial Results Revenue: US$16.3m (down 18% from FY 2022... › biotech › gritstone-lay...
Gritstone lays off 40% of team after delaying COVID vax trial
Feb 29, 2024 — Gritstone Bio is laying off 40% of employees after delaying the start of a phase 2 trial testing its COVID-19 vaccine, which in turn pushed ... › 2024/02/08 › cancer-vacci...
Gritstone Bio's cancer vaccine test, and more on Novartis' deal
Feb 8, 2024 — The Gritstone vaccine is designed to train a patient's own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, ...
Related Searches
Related Searches
gritstone bio stock
gritstone bio logo
Gritstone bio wikipedia
Knowledge Panel
Knowledge Panel

Gritstone bio (Biotechnology company)

Gritstone bio is a clinical-stage American biotechnology company which develops cancer and infectious disease immunotherapies and vaccines. It was founded in August 2015 as Gritstone Oncology, Inc., and is based in Emeryville, California. In September 2021 it raised $55.0 million from the sale of 5,000,000 shares.
  • Headquarters : Emeryville, CA
  • Founded : 2015

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194177